SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA

Kasahara Kaori; Moriyama Muka; Morohoshi Kei; Yoshida Takeshi; Simada Noriaki; Nagaoka Natsuko; Yokoi Tae; Shinohara Kosei; Kaneko Yuichiro; Suga Mitsuki; Ohno-Matsui Kyoko

首页> 外文期刊>Retina >SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA

【24h】

SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA

机译：病理学近视患者颈椎植物骨盆术治疗血管内血管形成的六年成果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To investigate the 6-year outcome of intravitreal bevacizumab (IVB) to treat eyes with active choroidal neovascularization (CNV) due to pathologic myopia.

机译：目的：研究由于病理近视，探讨了玻璃体外贝伐单抗（IVB）的6年结果，以治疗活性脉络膜新生血管（CNV）。

著录项

来源
《Retina》 |2017年第6期|共10页
作者
Kasahara Kaori; Moriyama Muka; Morohoshi Kei; Yoshida Takeshi; Simada Noriaki; Nagaoka Natsuko; Yokoi Tae; Shinohara Kosei; Kaneko Yuichiro; Suga Mitsuki; Ohno-Matsui Kyoko;
展开▼
作者单位

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

Tokyo Med &

Dent Univ Dept Ophthalmol &

Visual Sci Tokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
choroidal neovascularization; pathologic myopia; anti-VEGF therapy; bevacizumab; macular atrophy;

机译：脉络膜新生血管;病理近视;抗VEGF疗法;贝伐单抗;黄斑萎缩;

相似文献

外文文献
中文文献
专利

1. SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA [J] . Kasahara Kaori, Moriyama Muka, Morohoshi Kei, Retina . 2017,第6期

机译：病理学近视患者颈椎植物骨盆术治疗血管内血管形成的六年成果
2. Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes [J] . Sarao Valentina, Veritti Daniele, Macor Sara, Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie . 2016,第3期

机译：玻璃体腔注射贝伐单抗治疗病理性近视引起的脉络膜新生血管：长期结果
3. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series. [J] . Iacono P, Parodi MB, Papayannis A, Retina . 2011,第9期

机译：玻璃体腔注射贝伐单抗可根据需要用于继发于病理性近视的小凹下脉络膜新生血管：预期病例系列的2年结局。
4. Automatic Detection Of Pathological Myopia And High Myopia On Fundus Images [C] . Siying Dai, Leiting Chen, Ting Lei, IEEE International Conference on Multimedia and Expo . 2020

机译：在眼底图像上自动检测病理性近视和高度近视
5. Clinical Features of Treated and Untreated Type 1 Idiopathic Macular Telangiectasia Without the Occurrence of Secondary Choroidal Neovascularization Followed for 2 Years in Japanese Patients [D] . 逢坂理恵 2019

机译：在日本患者中治疗和未治疗的1型特发性黄斑部毛细血管扩张症的临床特征为继发性脉络膜新血管形成，随访2年
6. Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia [O] . J H Lee, S C Lee, S Choi, 2017

机译：玻璃体腔内贝伐单抗治疗脉络膜新生血管并伴有圆顶状黄斑的病理性近视的两年结局
7. Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia [O] . Rishi, Pukhraj, Rishi, Ekta, Venkataraman, Anusha, 2011

机译：玻璃体腔注射曲安奈德，贝伐单抗或兰尼单抗的光动力单药治疗或联合治疗与病理性近视相关的脉络膜新生血管形成

SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA

摘要

著录项

相似文献

相关主题

期刊订阅